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The basic helix-loop-helix transcription factor, Id1, was shown to induce tetraploidy in telomerase-immortalized naso-
pharyngeal epithelial cells in this study. Using both transient and stable Id1-expressing cell models, multiple mitotic
aberrations were detected, including centrosome amplification, binucleation, spindle defects, and microtubule perturba-
tion. Many of these abnormal phenotypes have previously been reported in cells overexpressing Aurora A. Further
experiments showed that Id1 could stabilize Aurora A, whereas knocking down Aurora A expression in Id1-expressing
cells could rescue some of the mitotic defects. The mechanisms by which Aurora A could be modulated by Id1 were
explored. DNA amplification of the Aurora A locus was not involved. Id1 could only weakly activate the transcriptional
activity of the Aurora A promoter. We found that Id1 overexpression could affect Aurora A degradation, leading to its
stabilization. Aurora A is normally degraded from mitosis exit by the APC/CCdh1-mediated proteasomal proteolysis
pathway. Our results revealed that Id1 and Cdh1 are binding partners. The association of Id1 and Cdh1 was found to be
dependent on the canonical destruction box motif of Id1, the increased binding of which may compete with the interaction
between Cdh1 and Aurora A, leading to stabilization of Aurora A in Id1-overexpressing cells.
INTRODUCTION
Id1 is a dominant-negative inhibitor of the basic helix-loop-
helix (bHLH) transcription factors. The Id1 protein lacks the
basic DNA binding domain and thus antagonizes the tran-
scriptional activity of many differentiation-specific bHLH
transcription factors by forming DNA binding-incompetent
heterodimers (Benezra et al., 1990). It has been reported that
Id1 could also interact with non-bHLH transcription factors
(Roberts et al., 2001) to interfere the Rb regulatory pathway
(Hara et al., 1996). Id1 suppresses cellular senescence (Ohtani
et al., 2001), and it facilitates immortalization by repressing
p16INK4A in human fibroblasts (Alani et al., 2001). Overex-
pression of Id1 is common in immortalized cells that have
escaped cellular senescence (Hara et al., 1994). In our previ-
ous study, Id1 expression was expressed in nasopharyngeal
epithelial cells before and after immortalization but not in
senescent cells (Li et al., 2006). Id1 overexpression has been
implicated in multiple human cancers, including nasopha-
ryngeal carcinoma (Wang et al., 2002). The role of Id1 in
tumor neo-angiogenesis and cancer metastasis has been ad-
dressed previously (Ruzinova et al., 2003; Minn et al., 2005).
Therefore, Id1 is being marked as an attractive target for
anticancer therapy. We have previously reported that the
Epstein–Bar virus encoded latent membrane protein 1 is able
to up-regulate Id1 expression in immortalized nasopharyn-
geal epithelial cells (Li et al., 2004). Apart from the involve-
ment of Id1 in facilitating cell immortalization, Id1 is also
implicated in mitotic regulation. Id1 could be localized to
the centrosomes (Hasskarl et al., 2004), and ectopic overex-
pression of Id1 could rapidly induce supernumerary centro-
somes in human foreskin keratinocytes, suggesting that Id1
could potentially contribute to carcinogenesis by centrosome
amplification. Recently, the same group has reported that
the ability of Id1 to induce supernumerary centrosomes may
correlate with the interaction of Id1 with the proteosomal
subunit S5A/Rpn10 (Anand et al., 1997; Hasskarl et al., 2007).
In addition, Id2 contains a destruction-box (D-box) recogni-
tion sequence for interacting with the anaphase-promoting
complex (APC/C) (Lasorella et al., 2006). The canonical D-
box motif is commonly present in Id proteins, including Id1,
suggesting that Id1 may also affect mitosis by interfering
with the APC/C.
Aurora A is a centrosome-localized mitotic kinase in-
volved in assembly and stability of mitotic spindle. The
Aurora A gene is located at chromosome position 20q13, a
site frequently amplified in breast and colorectal tumors
(Bischoff et al., 1998; Zhou et al., 1998; Bischoff and Plowman,
1999). Overexpression of Aurora A has been reported in
many tumor cells (Miyoshi et al., 2001; Goepfert et al., 2002;
Tatsuka et al., 2005). In vitro studies revealed multiple mitotic
abnormalities after Aurora A overexpression, including non-
functional bipolar spindle (Marumoto et al., 2003), cytokinesis
failure, polyploidy (Meraldi et al., 2002), and centrosome am-
plification (Miyoshi et al., 2001; Marumoto et al., 2003). Immor-
talized cells expressing the inactive form of Aurora A could
also result in tetraploidization (Anand et al., 2003; Marumoto et
al., 2003). That overexpression of active or inactive Aurora A
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always provokes aneuploidy and centrosome amplification
(Goepfert et al., 2002; Marumoto et al., 2003) suggests that
Aurora A is crucial for the induction of chromosome instabil-
ity; hence, it plays an important role in the early steps of
tumorigenesis. Despite the difficulties with chromosome align-
ment, Aurora A-overexpressing cells do exit mitosis (Anand et
al., 2003), but they may result in cytokinesis defects. Cells
lacking functional p53 may continue to cycle to form polyploid
intermediates and eventually achieve aneuploidy with ampli-
fied centrosomes (Meraldi et al., 2002). In somatic cells, Aurora
A levels are low during G1 and S phase, peak during G2 and
mitosis, and drop during mitotic exit into G1 phase of the next
cell cycle (Bischoff and Plowman, 1999). The protein is de-
graded during mitotic exit by the APC/CCdh1, which requires
Cdh1 as the coactivator. When Cdh1 recognizes and binds to
its substrates, including Aurora A, the ubiquitin reaction will
be activated, leading to proteasomal degradation of the sub-
strate (Crane et al., 2004; Pfleger et al., 2001; Taguchi et al., 2002;
Walter et al., 2000; Zachariae, 2004).
In this study, we reported that Id1 overexpression induces
multiple mitotic aberrations, many of which are mediated
through Aurora A. We demonstrate that Id1 could interact
with the anaphase-promoting complex coactivator, Cdh1, to
stabilize Aurora A. The binding ability between Id1 and
Cdh1 involves the Id1 D-box, which could be recognized by
the APC/CCdh1. Our study has revealed some of the mech-
anisms involved Id1 induction of abnormal mitotic pheno-
types in immortalized human epithelial cells and cancer cells.
MATERIALS AND METHODS
Establishment of Immortalized Nasopharyngeal Epithelial
Cell Line with Stable Expression of Id1 and Other Cell
Lines Used
The nasopharyngeal immortalized cell line NP460hTert was established pre-
viously in our laboratory (Li et al., 2006). The immortalized cells were main-
tained in a 1:1 ratio of defined keratinocyte-SFM (Invitrogen, Carlsbad, CA)
and EpiLife medium supplemented with growth factors (Sigma-Aldrich, St.
Louis, MO) at 37°C with 5% CO2. High level of expression of Id1 was induced
by retroviral transduction of Id1 into NP460hTert at population doubling 62.
The pcDNA expression plasmid of Id1 was a gift from Dr. E. Hara (Paterson
institute for Cancer research, Manchester, United Kingdom), which contains
the full-length human Id1 gene (Hara et al., 1994). The full-length Id1 gene
was subcloned into a retrovirus construct (pBabe-puro) as described previ-
ously (Ling et al., 2003). The construct, containing the retroviral vector, was
then transfected into PT67 packaging cells (BD Biosciences, Palo Alto, CA) to
produce infectious virus according to the manufacturer’s protocol. The retro-
viral supernatants were filtered and stored at 70°C until use. NP460 hTert
cells, plated at 1  105 cells/T25 flask, were transduced by adding the
retroviral supernatant plus 4 g/ml Polybrene (Sigma-Aldrich) for 6 h. After
infection, cells were selected with puromycin at 0.8 g/ml for a period of
14 d. Stable expression of Id1 in the NP460hTert-transduced cells
(NP460hTert-Id1) was confirmed by Western blotting. The HeLa cell line was
obtained from the American Type Culture Collection (Manassas, VA). The
HONE1 cell line was kindly provided by Dr. Ron Glaser (The Ohio State
University) (Yao et al., 1990). Both the HeLa and HONE1 cells were main-
tained in RMPI 1640 medium supplemented with 10% fetal calf serum (FCS)
(1% penicillin/streptomycin), and they were incubated at 37°C with 5% CO2.
The U2OS (osteosarcoma cell line) was from American Type Culture Collec-
tion. U2OS cells were maintained in DMEM supplemented with 10% FCS (1%
penicillin/streptomycin).
Transient Transfections and Construction of Id1
D-Box Mutants
Transient transfections were achieved using either FuGENE 6 transfection
reagent (Roche Molecular Biochemicals, Indianapolis, IN) or Lipofectamine
2000 (Invitrogen) according to the manufacturers’ recommendations. Forty-
eight hours after transfection, cells were either collected for immunoprecipi-
tation studies, Western blotting analysis, or examined by immunofluores-
cence analysis. The expression plasmids pDSRed (transfection marker) and
pEGFP--tubulin (microtubule marker) were obtained from Clonetech
(Mountain View, CA) (Rosa et al., 2006). The pcDNA-flag-Id1wt, pcDNA-N-
flag, pcDNA-C-flag was kindly provided by Dr. J. Hasskarl (Department of
internal medicine, University of Freiburg, Freiburg, Germany) (Hasskarl et al.,
2004). The Id1 D box mutants pcDNA-flag-Id1mDB126, pcDNA-flag-Id1mDB129,
and pcDNA-flag-Id1mDB133 were generated by QuikChange site-directed mu-
tagenesis kit from the pcDNA-flag-Id1wt plasmid (Stratagene, La Jolla, CA).
Mutagenic primers were designed using the Web-based QuikChange primer
design program. All sequences were verified by DNA sequencing.
Gene Silencing by Short Hairpin RNA (shRNA) and
Dual-Luciferase Analysis
The short hairpin RNA targeted specifically against Aurora kinase A (pSR-
shAURKA) and the empty vector (pSR-shGL2) were kindly provided by Prof.
Horii Akira (Tohoku University, Sendai Miyagi, Japan) (Hata et al., 2005). The
antisense expression plasmid pcDNA3-ASId1 was used as described previ-
ously (Ling et al., 2003). Gene silencing was achieved by transient transfection
into cell lines with high level of Aurora kinase A by using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol.
Dual-luciferase analysis was performed as described previously (Man et al.,
2007). Cells (1  106) were transiently cotransfected with 0.5 g of pcDNA3-
Id1 plasmid DNA and 0.5 g of different 5-deletion Aurora A promoter-
luciferase constructs (pGL1486, pGL189, pGL124, pGL75, and pGLbasic). The
promoter luciferase constructs were provided by Prof. Yoshiaki Ishigatsubo
(First Department of Internal Medicine, Tokyo Medical and Dental Univer-
sity, Tokyo, Japan) (Tanaka et al., 2002). To allow normalization of transfection
efficiencies between different plates, each transfection also contains 0.01 g of
promoter-driven Renilla luciferase reporter plasmid (pRL-conA). Constant
amount of DNA per transfection was ensured. Luciferase assay was per-
formed according to the manufacturer’s instructions (Dual-Luciferase Re-
porter kit, Promega, Madison, WI). Measurements of each data point were
taken on triplicate wells. The readings were normalized with the Renilla
luciferase activities. Three separate experiments were performed and the
error bars represent the SE of the means.
Cytogenetic Analysis and Fluorescent In Situ
Hybridization (FISH)
A complete cytogenetic profile of NP460 hTert and NP460 hTert-Id1 cells at
comparable population doublings were analyzed by conventional cytogenet-
ics method as described previously (Man et al., 2007). Thirty cells from
different passages of each cell line were karyotyped according to the Inter-
national System for Human Cytogenetic Nomenclature (ISCN 1995) using the
Cytovision software (Applied Imaging, San Jose, CA).
The PAC clone (RP5-843L14), located at chromosome 20q13.2 in which
Aurora A resides was obtained from Invitrogen (Chung et al., 2005). Another
PAC clone (RP5-1107C24), juxtaposed to RP5-843L14 labeled with spectrum
green, was used as an internal control. For each labeling, 0.5 g genomic DNA
was used. Random Primer Mix (Bioprime kit; Invitrogen) was added to the
DNA. The DNA/primer mix was denatured at 100°C and quenched on ice.
The DNA-labeling reaction was performed by combining DNA/Random
Primer mix, 10 dNTP (1.2 mM dATP, 1.2 mM dGTP, 1.2 mM dCTP, and 0.6
mM dTTP), Spectrum Red-dUTP (Vysis, Downer’s Grove, IL), 10 reaction
buffer, nuclease-free water and Klenow enzyme (50 U/l). The reaction was
incubated at 37°C overnight, and purified by the Quick Spin Sephadex G-50
spin column (GE Healthcare, Chalfont St. Giles, United Kingdom). The col-
lected flow through was precipitated with 3 M sodium acetate and cold
ethanol overnight. Labeled PAC clone was rehydrated with hybridization
buffer (Vysis) and human cot-1 DNA (Invitrogen). Chromosome spreads were
prepared as described previously (Man et al., 2007). The chromosomes were
denatured with 70% formamide/30% 2 SSC at 70°C. The hybridization,
washing, and image capturing procedures were performed as described
previously (Chung et al., 2005; Li et al., 2006).
Western Blotting and Immunoprecipitation Studies
A detailed protocol for Western blotting was described previously (Li et al.,
2006; Man et al., 2007). In this study, primary antibodies used and the optimal
concentration used for 25 g of protein lysates were Id1 (1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA), Aurora A (1:400; Santa Cruz Biotechnology),
cdh1 (1:500; Zymed Laboratories, South San Francisco, CA), Flag monoclonal
M2 (1:3000; Sigma-Aldrich), Plk1 (1:500; Bethyl Laboratories, Montgomery,
TX), Survivin (1:200; Zymed Laboratories), Aurora B (1:1000; Abcam, Cam-
bridge, United Kingdom), and -actin (1:1000; Santa Cruz Biotechnology,
CA). Expression of actin was used as loading control. For antibodies immu-
noblotted against nuclear proteins, histone was used as a loading control.
Relative protein expression levels were quantified by comparing the density
of the bands by using a gel documentation system (Ultraviolet Products, San
Gabriel, CA). Where indicated, 5 g/ml cylcloheximide was used to inhibit
protein synthesis; and 1 M MG132 (Calbiochem, San Diego, CA) was used
for preventing proteasomal-mediated proteolysis. For coimmunoprecipita-
tion studies on the interaction between Id1 and Aurora A/cdh1, 150 g of
lysates (transfected with either empty vector or Id1) were prepared: flag,
Aurora A, or cdh1 immunoprecipitates were recovered on protein A/G agarose
beads (Calbiochem, San Diego, CA) for 4 h at 4°C. The immunoprecipitated
complexes with sample buffer were subjected to electrophoresis on a 12.5%
SDS-polyacrylamide gel and immunoblotted with the specific antibodies.
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Immunofluorescence Staining
Cells grown on coverslips were fixed with methanol at 20°C. Conventional
immunofluorescence staining technique was performed as described previ-
ously (Man et al., 2007), with particular reference for immunofluorescent
staining of microtubule markers (Rosa et al., 2006). Antibodies used for
immunofluorescence staining included the following: murine monoclonal
anti--tubulin (Sigma-Aldrich), rabbit anti-centrin (Sigma-Aldrich), anti-rab-
bit-Id1 (Santa Cruz Biotechnology), anti-goat Aurora kinase-A (Santa Cruz
Biotechnology, CA), anti-mouse-DM1 (antibody against -tubulin) (Grom-
ley et al., 2003), anti-mouse monoclonal Flag M2 (Sigma-Aldrich), Alexa Fluor
488- or Alexa Fluor 568-conjugated secondary antibodies (Invitrogen) and
fluorescein isothiocyanate (FITC)-conjugated secondary antibody. Nuclei
were visualized with 4,6-diamidino-2-phenylindole (Vysis). For centrosome
scoring, at least 200 cells were evaluated in each cell line. Cells with three or
more -tubulin signals were considered abnormal. For mitotic spindle exam-
ination, 50 mitotic cells were examined in each cell line, and cells that lack
bipolar spindles were considered abnormal.
Cell Cycle Distribution Analysis, Cell Synchronization,
and Bivariate Antigen-DNA Flow Analysis
Cell cycle analysis was performed to confirm ploidy change on a flow cytom-
eter EPICS profile analyzer and analyzed using the ModFit LT2.0 software
(Beckman Coulter, Fullerton, CA). The cells (1  106) were fixed with cold
70% ethanol. Fixed cells were treated with DNase-free RNase followed by 100
g/ml propidium iodide staining to reveal the DNA content.
To obtain cells primarily in G1 phase and S phase, asynchronous cells were
treated with 6 M aphidicolin (Sigma-Aldrich) for 19 h. Cells were released
by washing twice in serum-free medium. For late G1 phase, cells were
reincubated in serum-containing medium for an additional 6 h before collec-
tion and an additional 8 h for S phase collection. HeLa cells were synchro-
nized in G2/M phase by 0.3 M nocodazole block for 12 h for immortalized
cells and for 15 h for HeLa cells. The efficacy of the synchronization was
confirmed by fluorescence-activated cell sorting (FACS).
Cells were fixed and washed with phosphate-buffered saline (PBS) supple-
mented with 2% FCS and 0.1% sodium azide. Resuspended cells were per-
meablized in 0.25% Triton X-100 for 10 min at 4°C and subjected to primary
antibody (1:40 dilution) overnight at 4°C. After washing, cells were incubated
with secondary antibody conjugated with FITC (1:100). Cellular DNA was
stained with propidium iodide (PI). Bivariate flow cytometric analysis was
performed by quantification of FITC and PI fluorescence by using 514-nm
bandpass filter and 600-nm bandpass filter, respectively. Data were inter-
preted using the EXPO2 flow cytometer analysis software (Beckman Coulter).
Live Cell Imaging and Time-Lapse Microscopy
Cells were seeded onto glass bottom microwell dishes (MatTek, Ashland,
MA) or 12-mm round coverslips for transient transfections. Confocal z-stacks
were imaged at defined zoom (63 objective, 2 zoom) and depth (0.2 m),
and they were acquired using a multiphoton confocal Zeiss LSM 510 micro-
scope (Carl Zeiss, Jena, Germany). Cells were maintained at 37°C with a
microincubator fitted to a microscope stage.
For time-lapse microscopy, live cells transfected with either pcDNA (empty
vector) or pcDNA-Id1 were grown in T25 flasks. The cultures were transferred
to a heated chamber (37°C, 5% CO2) and imaged for 16 h with the Zeiss LSM
510 microscope, equipped with a 40 Plan-Neo DIC 1.3 numerical aperture
objective. Pictures were taken every 10 min for 19 h by using the Axiocam
software (Carl Zeiss).
Statistical Analysis
Student’s t test was used where applicable. The mean percentage and SE of
three independent experiments and at least 200 interphase cells or 50 mitotic
cells evaluated per experiment are given. p  0.05 was considered as statis-
tically significant.
RESULTS
Stable and Transient Expression of Id1 Induce
Tetraploidization and Centrosome/Centriole Amplification
We have reported previously that overexpression of Id1 is
common in nasopharyngeal carcinoma (Wang et al., 2002).
The contribution of Id1 to the pathogenesis of nasopharyn-
geal carcinoma is not fully defined. We first examined the
effect of Id1 overexpression on chromosome instability in a
telomerase-immortalized nasopharyngeal epithelial cell line
(NP460hTert), which has a near-diploid karyotype. Estab-
lishment and detailed characterization of NP460hTert has
been described previously (Li et al., 2006).
Stable expression of Id1 in NP460hTert cells resulted in
30% tetraploids, indicating an effect of Id1 on mitosis (p 
0.0001) (Figure 1A). Previous studies have indicated that
centrosomal defects could be identified at an early prema-
lignant stage of carcinogenesis (Pihan et al., 2003); centro-
some amplification is also strongly associated with rapid
onset of aneuploidy (Goepfert et al., 2002; Pihan et al., 2003).
Furthermore, it has been reported that overexpression of Id1
could induce centrosome overduplication in human foreskin
keratinocytes (Hasskarl et al., 2004). We first sought to ex-
amine for the presence of centrosomal aberrations in our
immortalized nasopharyngeal epithelial cells stably express-
ing Id1 (NP460hTert-Id1), by using antibody against -
tubulin, a major component of centrosomes, (Figure 1B).
Single-nucleated cells with three or more centrosomes as
well as binucleated cells with more than four centrosomes
are considered abnormal. In NP460hTert-Id1 cells, abnormal
numbers of centrosomes was detected in 50% of the cells
(n  200), but 10% in control NP460hTert cells at equiva-
lent population doublings. To further eliminate the possibil-
ity that the observed effect of Id1 on centrosome abnormality
was the result of selective outgrowth of cell clones with
centrosome anomalies, transient expression of Id1 in HeLa
cells was performed for examination of centrosome aberra-
tion. A flag-tagged Id1 expression vector was used for track-
ing the Id1-expressing cells. Ectopic expression of Id1 was
confirmed by Western blotting analysis (Figure 1B). Similar
to the observation in NP460hTert-Id1 cells, fourfold increase
in supernumerary centrosomes was detected in HeLa cells
transiently expressing Id1 (Figure 1B).
To determine whether Id1 induced extra centrosomes is
due to interference on centriole homeostasis, we also per-
formed transient transfection of Id1 into U2OS cells stably
transfected with green fluorescent protein (GFP)-tagged cen-
trin to allow direct visualization of individual centriole (Fig-
ure 1C). The effect of Id1 expression in centriole homeostasis
in the U2OS cells expressing Id1 was observed at 48 h after
transfection. A twofold increase of extra centrioles in single-
nucleated (4) or binucleated cells (flag-positive) cells (8)
(n  200) (Figure 1C) was detected. Similar increase in
centriole numbers was noted in NP460hTertId1 cells by
immunofluorescent staining with the centrin antibody (Fig-
ure 1C).
Id1 Disrupts Bipolarity and Induces Multipolar Spindles
Ectopic Id1 expression also induced a high frequency of
mitotic spindle defects in cells. Most notable was the in-
crease in the percentage of cells with multipolar and mo-
nopolar spindles, revealed by immunofluorescent staining
with -tubulin. Twenty-six percent of the NP460hTert-Id1
cells revealed multipolar mitotic spindles and monopolar
spindles (n  50) (Figure 1D). Using live cell imaging, mul-
tipolar spindles were also observed in 23% of HeLa cells
(n  50) cotransfected with Id1 and GFP--tubulin (5:1
ratio), compared with 5% in the control cells (n  50) (Sup-
plemental Figure 1A). In both cell models, the frequency of
mono- and multipolar spindles observed in Id1-overexpress-
ing cells is lower than the frequency of extra centrosomes
observed (Figure 1, B and C), suggesting that some centro-
somes in the Id1-overexpressing cells do not possess mi-
crotubule-nucleating activity in mitosis (Supplemental
Figure 1B).
Id1 Induced Binucleation May Arise as a Consequence of
Defects in Cytokinesis
Quantitative analysis of the NP460hTert-Id1 cells revealed
that around one third of the Id1-overexpressing cells that
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Figure 1. Stable expression of Id1 induced tetraploidization. (A) Western blot confirming high level of Id1 expression following NP460 hTert
transduced with the Id1 gene. Representative karyotypes of NP460 hTert and NP460 hTert-Id1 performed by conventional cytogenetics.
Histogram showing the percentage of tetraploids in NP460 hTert transduced with either the empty vector pBabe or with pBabe-Id1. (B) Stable
expression of Id1 induced supernumerary centrosomes. Quantification of centrosomes in NP460hTert-pBabe and NP460hTert-Id1 cells.
Immunofluorescent staining by using Alexa Fluor 568-conjugated antibody against -tubulin. Maximum projections of z-stacks were taken.
Single-nucleated cells with more than two -tubulin foci and binucleated cells with more than four foci were quantified as abnormal.
Transient Id1 overexpression resulted in supernumerary centrosomes. HeLa cells transiently transfected either with pcDNA3 or pcDNA3-
flag-Id1 for 48 h, expression of Id1 confirmed by Western blotting. Flag-positive cells were scored for the centrosome number. Immunoflu-
orescent staining and quantification of centrosomes were performed as described. (C) Transient transfection of flag-tagged Id1 plasmid in
U2OS cells resulted in abnormal centriole number. U2OS cell line stably expressing GFP-centrin was used to allow visualization of individual
centriole. U2OS cells were either transfected with pcDNA3-flag-Id1 or the empty vector. Flag-positive cells were examined for centriole
number. Maximum projections of z-stacks of centrioles were taken. Histogram showing the number of extra centrioles (4) in single-
nucleated cells or (8) in binucleated cells. Stable expression of Id1 induced supernumerary centrioles. Quantification of centrioles in
C. Man et al.
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carried extra centrosomes were binucleated (Figure 1D). Con-
versely, binucleated cells were not common in NP460hTert-Id1
cells with normal number of centrosomes. This indicates that
the extra centrosomes in the binucleated cells may result from
cytokinesis defect.
Binucleated cells could be generated by cytokinesis failure
or cell–cell fusion (Nigg et al., 2002). To corroborate the
interpretation that high level of Id1 may affect cytokinesis,
time-lapse microscopy was performed in Id1-expressing
HeLa cells and control cells. After cotransfecting the Id1
with the DsRed expression plasmids (at a 5:1 ratio) for 36 h,
cells were followed by time-lapse microscopy for 16 h. Pic-
tures were taken every 5 min for a 16-h duration. Mitotic
cells were analyzed from metaphase cells when the con-
densed chromosomes lined up on the equatorial plane, to
the exit of mitosis after abscission of the cleavage furrow.
Id1-expressing cells exhibited a defect in mitotic exit. A
prolonged transition time from anaphase to abscission of
furrow was detected in Id1-expressing cells (37 5.6 min, n 
44), compared with (20 2.5 min; n  46) in control cells (p 
0.0001) (Supplemental Figure 1C). These observations sug-
gest that Id1 may interfere with the cytokinesis process
leading to binucleation and tetraploidization.
Id1 Perturbs Organization of Interphase Microtubules and
Integrity of Mitotic Spindles
In addition to abnormal number of spindle poles, we also
detected diminished GFP intensity that represents poorly
formed mitotic spindles in 12% (n  50) of the Id1-trans-
fected HeLa cells (Supplemental Figure 1D), compared with
2% in the control cells. This would imply that overexpres-
sion of Id1 also has pronounced effect on microtubule orga-
nization.
The ability of Id1 to perturb interphase microtubules has
not been reported previously. Failure of microtubule poly-
merization was detected in 45% of the NP460hTert-Id1 in-
terphase cells (Supplemental Figure 2A) compared with 3%
in control cells (n  200). The effect of Id1 overexpression on
microtubule polymerization was examined by live cell im-
aging in HeLa cells cotransfected with Id1 and GFP-tagged
-tubulin expression plasmids (5:1 ratio). Twenty-six per-
cent of HeLa cells transiently expressing Id1 resulted in loss
of microtubule integrity (Supplemental Figure 2A).
Id1 Up-Regulates Aurora A Expression
We next sought to identify molecular event(s) responsible
for the generation of the abnormal phenotypes induced by
Id1. Considering the role of several mitotic kinases in the
centrosome cycle, many of the Id1-induced phenotypes (tet-
raploidization, extra centrosomes, binucleation, monopolar/
multipolar mitotic spindles) are similar to the phenotypes
associated with Aurora A overexpression (Meraldi et al.,
2002). We further examined whether Id1 could up-regulate
Aurora A expression to induce these abnormal phenotypes.
Western blotting analysis of NP460hTert-Id1 cells revealed
up-regulation of Aurora A expression (Figure 2A). We then
examined the ability of Id1 to up-regulate Aurora A expres-
sion by transient transfection of Id1 into HeLa cells. Up-
regulation of Aurora A by transient Id1 expression could
also be demonstrated in HeLa cells in a dose-dependent
manner (Figure 2B).
Id1 Depletion Down-Regulates Endogenous
Aurora a Level and Suppresses Centrosome Amplification/
Microtubule Perturbation in Cancer Cells
To examine whether Aurora A overexpression may mediate
the abnormal mitotic phenotypes observed in Id1-overex-
pressing cells, we performed knockdown experiments using
shRNAs. An undifferentiated nasopharyngeal cancer cell
line, HONE1, was chosen for this part of the knockdown
study, due to its endogenous high levels of Aurora A and
Id1 as well as the presence of supernumerary centrosomes
(55%). Transfection of HONE1 cells with a previously char-
acterized Id1-antisense expression vector (pcDNA3-Id1AS)
(Ling et al., 2003) resulted in a marked reduction in Id1 level
(Supplemental Figure 2B). Id1 depletion in HONE1 cells also
resulted in a decrease in the endogenous Aurora A expres-
sion level (Supplemental Figure 2B), suggesting that over-
expression of Aurora A is dependent on Id1. In parallel, the
percentage of HONE1 cells with extra centrosomes was
reduced by fourfold and twofold, after suppression of Id1 or
Aurora A, respectively (Supplemental Figure 2C), indicating
that overexpression of Id1 plays an important role in medi-
ating supernumerary centrosomes in HONE1 cells. We also
reported previously that U2OS cells also have endogenous
supernumerary centrioles (Gromley et al., 2003) as well as
high level of Id1. The number of supernumerary centrioles
in U2OS cells stably expressing GFP-centrin was suppressed
by 2- to 3.5-fold, when transiently transfected with shAurA
alone, Id1-AS alone (Figure 2B). This set of knockdown
experiments indicates the involvement of Aurora A in me-
diating centrosome and centriole amplification in Id1-over-
expressing cells. When Id1 and shAurA plasmids were co-
transfected into U2OS cells, the extra centriole phenotype
was partially suppressed (Figure 2B), indicating that Id1 is
mediating some other events involved in centrosome regu-
lation.
Gene silencing studies, in HONE1 cells, were performed
to examine the role of Id1 and Aurora A in association with
the microtubule phenotype (Supplemental Figure 2D),
which was revealed by transiently expressing GFP-tagged
-tubulin, Id1 depletion suppressed the disturbed microtu-
bule organization in HONE1 cells by fourfold (Supplemen-
tal Figure 2D), suggesting that high level of Id1 expression is
responsible for the abnormal microtubule phenotype ob-
served. The defective microtubules of HONE1 cells could be
suppressed, but to a lesser extent, when Aurora A expres-
sion was silenced (Supplemental Figure 2D). This set of data
suggests that Id1-induced microtubule aberration might be
mediated through other factor in addition to Aurora A.
The above-mentioned findings were confirmed in a telom-
erase immortalized RPEhTert epithelial cells stably express-
ing GFP--tubulin, previously used in our microtubule stud-
ies (Rosa et al., 2006; Man et al., 2007). Exogenous expression
of Id1 in RPEhTert cells also induced abnormal interphase
microtubules and monopolar mitotic spindles (Figure 2C),
compared with the network-like microtubules in the control
Figure 1 (cont). NP460hTert-pBabe and NP460hTert-Id1 cells.
Immunofluorescent staining using Alexa Fluor 488-conjugated an-
tibody against centrin. Maximum projections of z-stacks were taken.
Single-nucleated cells with more than four centrin foci and binucle-
ated cells with more than eight foci were quantified as abnormal.
(D) Effect of Id1 overexpression on spindle polarity in NP460hTert
cells. Id1 induces multi- and monopolar spindles. Immunofluores-
cent staining using Alexa Fluor 568-conjugated antibody against
-tubulin. Maximum projections of z-stacks were taken. Cells with
either monopolar or multipolar spindles were quantified as abnor-
mal (n  50). Id1 induces formation of binucleated cells. NP460
hTert and NP460 hTert-Id1 cells were immunofluorescent stained
with -tubulin antibody (n  200). Percentage of binucleated cells
was quantified. Confocal microscopy was performed as previous.
Bars, 10 m.
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cells. Number of cells with perturbed microtubules/spindles
were suppressed by 50% when Aurora A expression was
depleted by shRNA in Id1-overexpressing cells (Figure 2C).
To ensure these phenotypic changes were not artifacts of
DNA transfection or cytotoxic effects, cells scoring for ab-
normal microtubule structures were checked under phase-
contrast microscopy for the presence of intact membrane
structure (Figure 2C). In addition, cells were subsequently
fixed and immunostained with DM1-tubulin to verify the
distorted microtubules (data not shown). Similar to the cen-
trosome scenario, partial rescue of the microtubule pheno-
types by Aurora A in both cell models overexpressing Id1
suggests that other events mediated by Id1 may be respon-
sible for the microtubule effect.
Mechanisms Involved in the Up-Regulation of Aurora A
by Id1
Because up-regulation of Aurora A seems to play a role in
mediating the abnormal phenotypes, we carried a series of
experiments to examine some of the plausible mechanisms
involved.
Induction of Aurora A by Id1 Is Not Related to Cell Cycle
The expression of Aurora A peaks at G2/M because of the
enrichment of this protein either to the centrosomes (Hirota
et al., 2003) or to the microtubule compartments (Lee et al.,
2001; Kinoshita et al., 2005). Aurora A is rapidly degraded
after anaphase, and it could be detected, weakly, after G1
phase of the next cell cycle (Castro et al., 2002b; Taguchi et al.,
2002). We examined whether the induction of Aurora A
expression by Id1 may be a result of cells accumulating at
G2/M phase of the cell cycle. FACS analysis did not reveal
significance accumulation of cells at G2/M in Id1-overex-
pressing HeLa cells (Figure 3A). Furthermore, elevated Au-
rora A expression could be detected in Id-1–expressing
HeLa cells synchronized at various phases of the cell cycle,
and the efficacy of successful synchronization was verified
by FACS analysis (Figure 3B).
The results in Figure 3B were further confirmed by biva-
riate antigen flow analyses (Figure 3C). Double immunoflu-
orescent staining, by using Aurora A antibody and PI stain-
ing of cellular DNA content, was performed in HeLa cells
expressing Id1 or the vector control. Isotypic control was
performed to reveal antibody background (data not shown).
Each spot represents an individual cell with a specific Au-
rora A level (y-axis) and DNA content (x-axis). Identical
reference lines were drawn in corresponding panels to assist
comparison of expression levels. Consistent with the results
from Figure 3B, Aurora A expression was lower at G1/S
phase but higher at G2/M phase in the cells transfected with
Figure 2. Aurora A mediates the mitotic defects in
Id1-overexpressing cells. (A) High expression level
of Aurora A in stable and transient Id1 overexpress-
ing cells. Detection of Aurora A expression level by
Western blotting in NP460hTert cells transduced
with the empty vector (pBabe) or with pBabe-Id1.
Expression of Aurora A in HeLa cells was detected
48 h after the cells were transfected with different
doses of pcDNA3-Id1. (B) Rescue of the centriole
phenotype by knocking down Aurora A/Id1 in live
U2OS cells stably expressing GFP-centrin. U20S cells
stably expressing GFP-centrin was cotransfected
with Id1 and DsRed (5:1) to detect the proportion of
cells with abnormal centriole numbers (n  4); and
compared with the effect of either Id1 depletion by
using an antisense expression plasmid, pcDNA3-
ASId1, or Aurora A knocked down using short hair-
pin RNA targeted specifically against Aurora kinase
A, pSR-shAURKA, or expressing both pcDNA-Id1
and pSR-shAURKA. Subsequent detection, confocal
microscopy, and quantification of centrioles were
performed as described in Figure 1C. (C) Aurora A
suppression rescued the abnormal microtubule phe-
notype in Id1 overexpressing RPEhTert cells. Exog-
enous Id1 expression in retinal pigment epithelial
(RPE) cells stably expressing GFP--tubulin was at-
tained by transient transfection, followed by confo-
cal microscopy 48 h after transfection. To ensure the
abnormal phenotypes were not artifacts of transfec-
tion or cytotoxic effects, cells were checked under
phase-contrast microscopy for the presence of intact
membrane structure. Live cells were subsequently
fixed and immunostained with (DM1) -tubulin
antibody and Alexa Fluor 568-conjugated secondary
antibody to verify the origin of the distorted fea-
tures. Merged images of GFP--tubulin and (DM1)
-tubulin were generated using the LSM510 Meta
software (Carl Zeiss). Experiments were repeated by
cotransfecting pcDNA-Id1 and pSR-shAurA or
transfecting with the empty vector alone. Microtu-
bule defects in live RPE-GFP--tubulin cells were
detected and quantified (n  200) by confocal imag-
ing as described. Bars, 10 m.
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control vector (Figure 3C). Id1-expressing cells revealed a
substantial increase of Aurora A level, revealed by the FITC
intensity above the identical reference lines, at all phases of
the cell cycle. The mean FITC intensities of both G1 and S
phase populations were at least four- to sixfold higher (p 
0.005) than the mean FITC intensities in the corresponding
controls (Figure 3C). The mean FITC intensity of the G2/M
phase population was two- to threefold higher (p  0.005)
than the intensity of the control (Figure 3C). Here, we show
that the increased Aurora A level by Id1 is not a conse-
quence of redistribution of cells to the G2/M phase of the
cell cycle.
Gene Amplification Is Not Involved in the Elevated
Aurora A Level by Id1
Our previous studies had identified amplification of 20q13.2
as a nonrandom event during immortalization in human
ovarian epithelial cells, in which numerous copies of Aurora
A were mapped to homogeneous staining regions (hsr) on
chromosome 20q13 (Chung et al., 2005). In breast and ovar-
ian cancer cell lines, a 2.5- to 8-fold amplification of Aurora
A accounted for its high expression (Zhou et al., 1998). The
possibility that Aurora A gene was amplified in NP460 hTert-
Id1 cells were examined using the PAC clone (RP5843L14),
which mapped to the chromosomal locus of Aurora A. An-
other PAC clone (RP5-1107C24) juxtaposed to RP5843L14
was cohybridized to metaphases as internal control. Two
normal signals from each PAC clone (RP5-843L14 and RP5-
1107C24) were revealed in NP460hTert (n  200) (Figure
4A). NP460 hTert-Id1 cells did not reveal any multiple tan-
dem gene copies mapped on 20q13.2 (Figure 4A). Two extra
signals detected in NP460 hTert-Id1 cells (Figure 4A) were
due to the induction of tetraploid progeny by Id1. The third
extra signal was arisen from the immortalization process (Li
et al., 2006). Our data suggest that Aurora A amplification is
an unlikely mechanism for the elevated Aurora A level
detected in NP460 hTert-Id1.
Elevated Aurora A Expression in Id1-expressing Cells
Only Partially Resulted from Transcriptional Activation
of the Promoter of Aurora A
We then examined whether Id1 may result in transcriptional
up-regulation of Aurora A promoter activity by luciferase
reporter assay. HeLa cells were cotransfected with various
Figure 3. Id1 up-regulates Aurora A expression throughout the cell cycle. (A) FACS analysis showing the cell cycle distribution of the HeLa
cells transfected with the vector control or the Id1 expression plasmid. (B) Aurora A expression levels were detected in Id1-overexpressing
HeLa cells, and cells were transfected with vector control. Western blotting studies were performed in unsynchronized cells and in cells
synchronized at different phases of the cell cycle by using aphidicolin and nocodazole. U denotes unsynchronized cell population. FACS
analysis was used to verify successful synchronization. (C) Bivariate antigen DNA flow analysis confirmed Aurora A up-regulation by Id1
in all phases of the cell cycle. Aurora A expression and DNA content in HeLa cells expressing either Id1 or the empty vector was detected
by bivariate FACS. Aurora A was detected in cycling cells by immunofluorescent staining using Aurora A and FITC-conjugated antibodies.
DNA content was measured by PI staining. Each spot represents an individual cell with a specific Aurora A level (y-axis) and DNA content
(x-axis).
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5-truncated Aurora A promoter luciferase constructs
(pGL1486, pGL189, pGL124, and pGL75) and the Id1 expres-
sion plasmid (or the pGL basic vector). A 1.5- to 2-fold
increase in Aurora A promoter activities was observed in
Id1-transfected cells, the activity being highest between
189 and124 of the core promoter (Figure 4B). Our results
suggest that Id1 may regulate the transcriptional activity of
Aurora A at its core promoter between the 124 to 189
from the transcription start site. This weak increase in pro-
moter activation (do not exceed 2-fold) in Id1-expressing
cells indicates that transcriptional activation of Aurora A by
Id1 may not be the mechanism involved in its up-regulation.
Id1 Affects Aurora A Degradation
Aurora A is rapidly degraded at mitotic exit by the protea-
somal proteolysis pathway (Littlepage and Ruderman,
2002). We examined whether Id1 overexpression may affect
this process. The endogenous turnover rate of Aurora A was
detected in HeLa cells by treatment with cycloheximide, a
protein biosynthesis inhibitor in eukaryotic cells. The endog-
enous Aurora A in HeLa cells has a rapid turnover rate with
a half-life of 	2 h (Figure 4C). In line with other studies, we
confirmed that degradation of Aurora A in HeLa cells could
be prevented by proteasomal inhibition by using MG132
(inhibitor of the proteasomal degradation pathway) (Figure
4C). Furthermore, Aurora A could not be degraded in Id1-
overexpressing cells, even in the presence of cycloheximide,
indicating that Id1 overexpression resulted in stabilization
of Aurora A (Figure 4D).
Aurora A and Id1 Are Not Binding Partners
Aurora A is a known substrate of the anaphase-promoting
complex. This protein contains the D-box and the A-box
sequences known to be required for the recognition and
destruction by the activated APC/CCdh1 (Pfleger et al., 2001;
Castro et al., 2002a,b; Crane et al., 2004) at mitotic exit and
during the following G1 phase. To examine whether the
resistance of Aurora A to proteasomal degradation by Id1
overexpression could be a result of direct interaction be-
tween Id1 and Aurora A, we performed coimmunoprecipi-
tation studies. HeLa cells were transfected with a wild-type
Id1 flag-tagged expression vector. Coimmunoprecipitation
studies using the flag and Aurora A antibodies as baits failed
to reveal any interaction between Id1 and Aurora A (Figure
5A).
Binding of Id1 to the Anaphase-promoting Complex
Coactivator (cdh1) Affects the Stabilization of Aurora A
The APC/CCdh1 targets Aurora A for the ubiquitin protea-
somal-dependent degradation. The enzymatic E3 ubiquitin
ligase activity of APC/C requires Cdh1 as one of the coac-
tivators at late mitosis (Pfleger et al., 2001; Littlepage and
Figure 4. Mechanism(s) involved in Aurora A
up-regulation by Id1. (A) Overexpression of Au-
rora A in NP460 hTert-Id1 cells is not a conse-
quence of gene amplification. FISH analyses of
NP460 hTert and NP460 hTert-Id1 cells by using
the PAC clone (RP5-843L14), which resides at
the locus of Aurora A; another PAC clone (RP5–
1107C24), juxtaposed to the locus of Aurora A,
was used as an internal control. The PAC clones
were labeled with Spectrum red and Spectrum
green, respectively, by random priming. (B) Au-
rora A promoter activity is mildly enhanced by
Id1. Schematic representation of the 5-truncated
Aurora A promoter-luciferase constructs and
their activities in HeLa cells. HeLa cells were
transiently transfected with the 5-truncated Au-
rora A promoter-luciferase constructs. Results
were expressed as the ratio of luciferase activity
in each extract relative to the extract transfected
with pGL-basic. This set of result was compared
with a second set of result, in which HeLa cells
were cotransfected with Aurora A promoter-
luciferase constructs and the Id1 expression
plasmid. (C) Inhibition of proteolytic degrada-
tion of Aurora A degradation by Id1 expression.
Degradation of Aurora A is mediated through
the ubiquitin–proteasome pathway. Degrada-
tion profile of Aurora A protein was examined
by blocking protein synthesis by cycloheximide
for 2 h. The effect of proteasome inhibitor on
Aurora A stability was examined, by treating
the cells with cycloheximide together with 1 M
MG132. Western blotting analysis was per-
formed on the protein pellets collected at the
indicated time points. Expression of Id1 led to
stabilization of Aurora A in HeLa cells. Cells
were either transfected with the control vector
or the Id1 expression plasmid for 48 h. The
transfected cells were treated with cyclohexi-
mide after transfection for the indicated time
points. The level of Aurora A was examined by
Western blotting.
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Ruderman, 2002; Castro et al., 2002b; Crane et al., 2004). Cdh1
can recognize APC/C substrates by interacting with specific
recognition elements (D-box) in these substrates (Kraft et al.,
2005). It has been reported previously that Aurora A could
be immunoprecipitated with Cdh1 (Crane et al., 2004). Sta-
bility of Aurora A could be associated with depletion of
Cdh1 expression in somatic, cells whereas restoration of
Cdh1 rapidly induces fall in Aurora A level (Taguchi et al.,
2002; Crane et al., 2004). We then explored whether Id1
associates with Cdh1 and competes for the binding of cdh1
to Aurora A. Our coimmunoprecipitation studies revealed
that Id1 and cdh1 are indeed interacting partners (Figure
5B). Excessive Id1–cdh1 interaction could inhibit the associ-
ation between Aurora A and Cdh1 (Figure 5B). Hence, de-
creased recognition or binding of Cdh1 with Aurora A may
result in stabilization of Aurora A.
Id1C Fails to Induce Cdh1/Aurora A Dissociation and
the D-Box Motif in the C-Terminal of Id1 Is Involved in
Its Binding to Cdh1
We next investigated on the functional domain(s) of Id1
responsible for the dissociation of Cdh1 and Aurora A.
Immunoprecipitation studies were performed on cells ex-
pressing the wild-type Id1 and other Id1 mutants. Decreased
Cdh1 and Aurora A association was clearly observed in cells
expressing the wild-type Id1 (Figure 5C). Inhibition of Cdh1
Figure 5. Id1 affects Aurora A degradation.
(A) Id1 and Aurora A are not interacting pro-
teins. HeLa cells were transfected with flag-
tagged Id1 expression plasmid or the control
vector. Cellular extracts were sequentially im-
munoprecipitated with either rabbit immuno-
globulin G (IgG), anti-Flag M2, or anti-Aurora
A antibodies. The immunoprecipitates were
recovered on protein A/G and analyzed by
Western blotting to confirm successful pull-
down, and subsequent examination for the
potential interactions between Id1 and Au-
rora A. (B) Id1 and cdh1 are novel binding
proteins. Binding of Id1 to cdh1 affects Cdh1
association with Aurora A. Transfection of
HeLa cells and coimmunoprecipitation stud-
ies were performed as described in A. Cellu-
lar extracts were sequentially immunopre-
cipitated with either rabbit IgG, anti-Flag M2,
or anti-Cdh1 antibodies. The immunoprecipi-
tates were recovered on protein A/G and an-
alyzed by SDS-polyacrylamide gel electro-
phoresis (PAGE) and Western blotting for
the presence of Id1, Cdh1, and Aurora A in
the pulled-down complex. (C) Mapping of the
domain of Id1 essential for Cdh1–Aurora A
association. Cells were transfected with the
Id1 wild-type expression plasmid and the
mutants, respectively. The Id1-mHLHV98G
comprises a point mutation in the second he-
lix domain at amino acid 98, resulting in a
substitution of V to G. The Id1-N lacks the
amino terminal (1-64 amino acids), whereas
the Id1-C lacks the carboxy terminal 44
amino acids. Transfected cell lysates were im-
munoprecipitated with anti-cdh1 antibody,
recovered on protein A/G, and processed for
SDS-PAGE and Western blotting to confirm
successful pull-down as described. The pull-
down complexes were subsequently exam-
ined for the presence of Aurora A by Western
blotting. (D) The destruction box (D-box) mo-
tif within the C-terminal of Id1 is involved in
its binding to Cdh1. Id1 D-box mutants were
generated as described in text. HeLa cells
were transfected with the indicated expres-
sion plasmids carrying mutations of the D-
box at amino acids 126R-P, 129L-V and
133 N-K; the Id1 wild type; Id1-N, Id1-C,
the Id1-mHLHV98G; or the vector control ex-
pression plasmids. Transfected cell lysates
were immunoprecipitated with anti-Flag M2
antibody, recovered on protein A/G, and pro-
cessed for SDS-PAGE and Western blotting to
confirm successful pull-down. The pulled down complexes were subsequently examined for the presence of Cdh1 by Western blotting. (E)
Mapping of the domain of Id1 essential for Aurora A stabilization. HeLa cells were transfected with the Id1 wild-type expression plasmid
and the mutants Id1-mHLHV98G, Id1-N, and Id1-C, respectively. Western blotting was performed to monitor the effect of the Id1 domain
required for stabilization of Aurora A.
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and Aurora A association was also observed in cells express-
ing the Id1 mutant carrying a specific mutation at residue 98
of the second helix. Deletion of the C-terminal 44 amino
acids resulted in a full recovery of Cdh1/Aurora A associ-
ation; indicating that the C terminus of Id1 comprises a motif
that may be crucial for Cdh1/Aurora A recognition (Figure
5C). It was also noted that deletion of the N-terminal 65
amino acids resulted in weak recovery of Cdh1/Aurora A
association; suggesting the possible involvement of the Id1
N terminus in Cdh1/Aurora A association.
The APC/CCdh1 targets mitotic proteins for ubiquitin-
mediated degradation mostly through the D-box recognition
sequence/motif (RxxLxxxN) (Zachariae, 2004), and it has
been reported that the Id2 protein contains this recognition
sequence for interacting with the APC/C (Lasorella et al.,
2006). Apparently, this motif is also present in Id1 and Id4.
We then focused on the C terminus (residues 126-133) of Id1
(in which the D box is located), and we examined whether
this motif is essential for the interaction between Id1 and
Cdh1. Three flag-tagged Id1 mutants with mutations at spe-
cific residues within the destruction box (mDB126, mDB129,
and mDB133) were generated, and their binding abilities
with Cdh1 were examined (Figure 5D). We showed that
these DB mutants, as well as Id1C-flag, are less effective to
precipitate Cdh1 than Id1wt-flag, indicating that the de-
struction box recognition motif (residues 126-133) is re-
quired for Id1–Cdh1 association. Results from Figure 5, B–D,
suggest that Id1 promotes binding with Cdh1 at the destruc-
tion box and that it does inhibit Cdh1 to bind to its substrate,
Aurora A.
If Id1 inhibits APC/CCdh1, it should thereby accumulate
Aurora A at late M phase and at G1. According to the results
from Figure 5D, one would expect that expression of wild-
type Id1, Id1-N, and Id1-mHLH, but not the Id1-C (which
lacks the D box) could stabilize Aurora A level. Indeed,
Aurora A level was shown to accumulate in cells expressing
wild-type Id1, compared with cells expressing the vector
control (Figures 2A, 3, B and D, 4D, and 5E). Aurora A level
was seen accumulated in cells expressing the Id1-N as
expected, but at a relatively lower level compared with
wild-type Id1. However, our results showed that Aurora A
level could still be detected in cells expressing the Id1-C
mutant (Figure 5E), albeit at a lower level compared with
wild-type Id1; furthermore, Aurora A expression was not
detected in cells expressing the Id1-mHLH mutant. These
unexpected results indicate that other molecular events or
motifs at the N terminus/HLH domain may possibly affect
Aurora A stabilization (see Discussion). The D-box motif at
the C terminus of Id1 that binds to Cdh1 may not be the sole
mechanism in modulating Aurora A stabilization in cells.
Stabilization of Other Cdh1 Substrates Because of
Excessive Id1–cdh1 Association
If Id1–Cdh1 association is involved in stabilization of Au-
rora A, one would also expect accumulations of other Cdh1
substrates to occur in Id1-overexpressing cells. We next ex-
amined the levels of selected Cdh1 substrates (Aurora B,
Cyclin B1, Plk1, and Survivin) in Id1-overexpressing cells
synchronized at either G1/S or G2/M phases of the cell
cycle. Similar to the Aurora A scenario, stabilization of Au-
rora B, Plk1, Cyclin B1, and Survivin was detected in G1 and
M phase of the Id1-overexpressing cells (Figure 6A).
Immunoprecipitation studies were then performed (Fig-
ure 5B) to examine the degree of binding between Cdh1 and
the selected substrates. In agreement with our hypothesis,
decreased association of Cdh1 to these substrates was gen-
erally observed in cells overexpressing wild-type-Id1 (Fig-
ure 6B), compared with the vector controls. Id1C mutant,
which lacks the D box, failed to block the interactions be-
tween Cdh1 and its substrates, whereas wild-type Id1,
Figure 6. Stabilization of other Cdh1 substrates due to excessive
Id1–cdh1 association. (A) Levels of selected cdh1 substrates in
Id1-overexpressing cells were examined. Cells were transfected
with either the control vector or the Id1 wild-type expression plas-
mid. The transfected cells (24 h after transfection) were synchro-
nized at G1/S and G2/M phases of the cell cycle by using 6 M
aphidicolin and 0.3 M nocodazole for the durations described. The
expression levels of Aurora B, Plk1, Cyclin B1, and Survivin were
analyzed in Id1-overexpressing cells and control cells by Western
blotting. (B) Binding of Id1/Cdh1 masked the ability of Cdh1 to
form complexes with its substrates. Transfection of HeLa cells and
immunoprecipitation studies were performed as described in Fig-
ure 5, A and B. Cellular lysates were immunoprecipitated with
either rabbit IgG or anti-Cdh1 antibodies. The immunoprecipitates
were recovered on protein A/G and analyzed by SDS-PAGE and
Western blotting for the presence of Id1, Cdh1, Aurora B, Cyclin B1,
Plk1, and Survivin in the pulled-down complex. (C) Mapping of the
domain of Id1 essential for stabilization of Cdh1 substrates. HeLa
cells were transfected with wild-type Id1, Id1C, Id1-N, and Id1-
mHLH mutants. The domain(s) required for Cdh1–substrate asso-
ciations were examined by immunoprecipitation using the anti-
Cdh1 antibody. The immunoprecipitates were recovered on protein
A/G and analyzed by SDS-PAGE and Western blotting for the
presence of Cdh1, Plk1, Survivin, and Aurora B.
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Id1-N and Id1-mHLH mutants retain their abilities to block
the associations of Cdh1 to these Cdh1-specific substrates
(Figure 6C). Although the general trend is clear, still it is
unclear why the degree of inhibition of cdh1–substrate bind-
ings varies in cells transfected with the mutants. That is,
whereas the level of Survivin associated with Cdh1 is re-
duced with the Id1-N mutant more effectively than the
wild-type Id1, the level of Plk1 associated with Cdh1 is
reduced the same as the wild-type Id1. The N terminus and
the HLH domain of Id1 may also participate in regulating
the recognition and binding of Cdh1 to these targets. The
complexities of the molecular events involved warrant fur-
ther experiments. Nonetheless, our results suggest that the
destruction box motif within the Id1 C terminus is involved
in inhibiting Cdh1 to interact with Aurora A and other
specific substrates (Figure 6C).
DISCUSSION
Overexpression of Id1 is common in human cancers includ-
ing nasopharyngeal carcinoma (Wang et al., 2002). This pro-
tein is commonly detected in immortalized epithelial cells
that escaped senescence (Li et al., 2006), implying that over-
expression of Id1 may be an early event during cancer
development. Our data indicate that Id1 could induce mul-
tiple mitotic defects and tetraploidization.
Proper cell divisions involve tight regulation of multiple
events. Perturbations in microtubule organization and dy-
namics, defective spindle polarity, centrosome aberrations,
and altered kinetochore functions have been reported to
induce abnormal mitotic phenotypes in cells. Some of which
may be involved in the abnormal mitotic phenotypes in-
duced by Id1. In line with other studies (Hasskarl et al., 2004,
2007), we also detected rapid induction of supernumerary
centrosomes and centrioles at a significant rate in our im-
mortalized epithelial cells transduced with Id1. Several pro-
teins are involved in the regulation of centrosome duplica-
tion and tetraploidization. These include p53 inactivation
and p21Cip down-regulation (Meraldi et al., 2002; Fujiwara et
al., 2005). However, alteration of p53 level or mutation was
not detected in NP460hTert-Id1 cells (data not shown);
therefore, it is unlikely that the abnormal induction of cen-
trosomes by Id1 is mediated through p53. In the p21 sce-
nario, all Id proteins (Id1–4) are capable to inhibit p21Cip
expression; however, only Id1 was reported to be able to
induce centrosome amplification (Ohtani et al., 2001; Has-
skarl et al., 2004). Therefore, down-regulation of p21Cip ex-
pression per se may not be sufficient for centrosome ampli-
fication.
The role of Aurora A in centrosome homeostasis is well
documented (Marumoto et al., 2003; Terada et al., 2003; Fu-
jiwara et al., 2005). Overexpression of Aurora A has been
previously shown to induce centrosome amplification in
vitro and in vivo (Zhou et al., 1998; Goepfert et al., 2002;
Meraldi et al., 2002). Centrosome amplification in Aurora
A-overexpressing cells could be a consequence of cytokine-
sis failure, resulting in the formation of binucleated cells
(Meraldi et al., 2002; Terada et al., 2003). In this study, we
found that many of the Id1-induced mitotic defects mirrored
those of Aurora A overexpression. In this study, we have
examined in details the involvement of Aurora A stabiliza-
tion as a mechanism involved in mediating the abnormal
mitotic phenotype induced by Id1. Depletion of Aurora A by
short hairpin RNA effectively was found to rescue centroso-
mal aberrations and spindle defects in 
50% of the Id1-
overexpressing cancer cells. Possible mechanisms involved
in the activation of Aurora A by Id1 were explored. Among
which is to use FISH analyses in showing that the Aurora A
locus was not amplified in Id1-overexpressing cells. Further-
more, we showed that Id1 could weakly activate the Aurora
A promoter, but the extent of activation may only partially
explain the high level of Aurora A observed in Id1-express-
ing cells.
The fidelity of cell division is dependent on the accumu-
lation and orderly destruction of critical mitotic regulators.
Aurora A expression is known to be controlled by degrada-
tion through the APC–ubiquitin–proteasome pathway,
which occurs at the end of mitosis through the G1 phase of
the following cell cycle (Walter et al., 2000; Taguchi et al.,
2002). We showed that overexpression of Id1 could effec-
tively inhibit the degradation of Aurora A in cells. The
inhibition of proteolytic degradation is not the result of
direct interaction of Id1 with Aurora A as revealed by the
coimmunoprecipitation studies. Other mechanisms in-
volved in stabilizing Aurora A were explored. Among them
is the binding of the APC/C coactivator Cdh1 with Id1,
which was shown to mask the ability of Cdh1 to form
complex with Aurora A and to play an important role in
stabilization of Aurora A in cells. However, an unexpected
result was observed in Figure 5E, showing that deletion of
the binding domain inside the C terminus of Id1 (Id1C)
could only result in partial destabilization of Aurora A in
cells, suggesting additional events are involved in stabiliza-
tion of Aurora A. A plausible explanation is that Id proteins
could inactivate the ubiquitin proteasome system and affect
the degradation of Aurora A in our study. Id1 could bind to
various components of the 26S proteasome including the
S5A subunit of the 19S proteasome (Anand et al., 1997;
Hasskarl et al., 2007) and the JAB1 protein (Berse et al., 2004).
The S5A subunit contains an ubiquitin-interacting motif do-
main involved in the recognition and shuttling of the polyu-
biquitinated substrates to the proteolytic 20S degradation
chamber of the proteasome (Hershko and Ciechanover,
1998). The Id1N and HLH domains are essential for bind-
ing to the S5A (Hasskarl et al., 2007), which interfere with the
ubiquitin proteasome system. Id1 mutant that lacks the C-
terminal domain (Id1C) could still efficiently bind to the
S5A proteasomal subunit (Hasskarl et al., 2007), and it may
block the presentation and ubiquitination of Aurora A for
proteasomal degradation, resulting in its incomplete desta-
bilization. Hence, the results in Figure 5E reflect the combi-
nation effects of Cdh1 binding to the Id1 C-terminus D box
and S5A binding to the Id1 N terminus and the HLH
domain.
We further demonstrated that strong interaction of Id1
with cdh1 compromised the binding of Cdh1 to its specific
substrates, such as Aurora B, Survivin, and Plk1. Stabiliza-
tion of such proteins would also lead to significant mitotic
perturbations such as defective microtubule–kinetochore in-
teraction, disorganized interphase microtubules, supernu-
merary centrosomes, cytokinesis failure, and ploidy (Ota et
al., 2002; Honda et al., 2003; Araki et al., 2004; Yokoyama et
al., 2005). Some of these phenotypes were also observed in
this study. This could further explain the fact that Aurora A
knockdown rescued 50% of the phenotypes of Id1 overex-
pression and that knocking down Id1 expression could effi-
ciently rescue these phenotypes. Preliminary observations
revealed that the interphase microtubule effect induced by
Id1 could be rescued by silencing Survivin and Aurora B in
Id1-overexpressing cells (data not shown). Detailed mecha-
nistic study of the disturbance of microtubule defects in
mitotic exit induced by Id1 is under investigation. APC/C
activity is tightly regulated by coactivators and inhibitors. In
this study, Id1 can antagonize Cdh1. This competing action
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of Id1 with Cdh1’s bindings to its substrates is similar to
another Cdh1 inhibitor Emi-1 (Reimann et al., 2001). Same as
the Emi-1 scenario where it can competitively bind to Cdh1
and allow accumulation of substrates at G1/S, we are also
uncertain whether this in vitro action of Id1 could explain
the capability of Id1 to inhibit APC/CCdh1 in vivo. The
precise in vivo mechanism(s) warrants further investigation.
In this study, we report that Id1 could induce multiple
abnormal phenotypes of mitosis and also the involvement of
the Id1–Cdh1–Aurora A axis in mediating these phenotypes.
Id1 overexpression is common in human cancers. The in-
duction of abnormal mitotic phenotypes could possibly lead
to aneuploidy commonly observed in malignant tumors.
Our results support the role of Id1 in the induction of mitotic
dysregulation in early-staged carcinogenesis and in facilitat-
ing tumor progression.
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